Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Generation Bio Co. (GBIO)

Generation Bio Co. (GBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 198,766
  • Shares Outstanding, K 66,477
  • Annual Sales, $ 5,900 K
  • Annual Income, $ -126,610 K
  • 60-Month Beta 2.79
  • Price/Sales 36.71
  • Price/Cash Flow N/A
  • Price/Book 0.91
Trade GBIO with:

Options Overview Details

View History
  • Implied Volatility 303.23% ( +9.15%)
  • Historical Volatility 112.09%
  • IV Percentile 93%
  • IV Rank 57.49%
  • IV High 507.20% on 10/23/23
  • IV Low 27.45% on 08/16/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 10
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 205
  • Open Int (30-Day) 956

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.36
  • Number of Estimates 4
  • High Estimate -0.27
  • Low Estimate -0.51
  • Prior Year -0.53
  • Growth Rate Est. (year over year) +32.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.70 +11.48%
on 04/19/24
4.65 -35.27%
on 04/01/24
-0.20 (-6.23%)
since 03/25/24
3-Month
1.75 +72.00%
on 01/29/24
4.65 -35.27%
on 04/01/24
+1.21 (+67.22%)
since 01/25/24
52-Week
0.86 +250.00%
on 10/25/23
6.98 -56.88%
on 07/12/23
-1.60 (-34.71%)
since 04/25/23

Most Recent Stories

More News
Stocks Set to Open Lower as Investors Await Key U.S. Inflation Data and Big Tech Earnings

December S&P 500 futures (ESZ23) are down -0.76%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.92% this morning as the benchmark U.S. 10-year yield hit 5% for the first time since 2007 while...

ESZ23 : 4,694.27s (-0.58%)
NQZ23 : 16,530.23s (-0.07%)
SEDG : 56.61 (-2.16%)
AXP : 237.10 (-0.84%)
RF : 19.61 (-0.81%)
KNX : 47.14 (-2.82%)
MSFT : 399.04 (-2.45%)
GOOGL : 156.00 (-1.97%)
V : 275.16 (+0.05%)
KO : 61.74 (+0.31%)
META : 441.38 (-10.56%)
BA : 166.81 (+1.51%)
Generation Bio Co. (GBIO) Reports Q1 Loss, Misses Revenue Estimates

Generation Bio Co. (GBIO) delivered earnings and revenue surprises of -35.90% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

GBIO : 3.01 (+0.67%)
FIXX : 16.8246 (+0.77%)
Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio

Moderna (MRNA) collaborates with Generation Bio to develop non-viral genetic medicines. For this, it leverages the latter's closed-end DNA (ceDNA) and cell-targeted LNPs (ctLNP) technologies.

MRNA : 106.18 (-2.45%)
CRSP : 53.73 (-3.45%)
GBIO : 3.01 (+0.67%)
JSPR : 21.18 (-3.86%)
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines

Collaboration will extend the applications of each company's platform through discovery and development of novel lipid nanoparticles using Generation Bio's proprietary stealth cell-targeted lipid nanoparticle...

MRNA : 106.18 (-2.45%)
GBIO : 3.01 (+0.67%)
Can Generation Bio Co. (GBIO) Climb 184% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 183.8% in Generation Bio Co. (GBIO). While the effectiveness of this highly sought-after metric is questionable,...

GBIO : 3.01 (+0.67%)
Wall Street Analysts Think Generation Bio Co. (GBIO) Could Surge 176%: Read This Before Placing a Bet

The consensus price target hints at a 176% upside potential for Generation Bio Co. (GBIO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...

GBIO : 3.01 (+0.67%)
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates

Generation Bio Co. (GBIO) delivered earnings and revenue surprises of -4.76% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

GBIO : 3.01 (+0.67%)
VIVO : 33.97 (unch)
Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results

Cash balance of $312.2M expected to fund operations into 2025...

GBIO : 3.01 (+0.67%)
Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 3.01 (+0.67%)
Generation Bio Appoints Dannielle Appelhans to Its Board of Directors

CAMBRIDGE, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 3.01 (+0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 3.41
2nd Resistance Point 3.25
1st Resistance Point 3.13
Last Price 3.01
1st Support Level 2.85
2nd Support Level 2.69
3rd Support Level 2.57

See More

52-Week High 6.98
Fibonacci 61.8% 4.64
Fibonacci 50% 3.92
Fibonacci 38.2% 3.20
Last Price 3.01
52-Week Low 0.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar